Method of treating multiple sclerosis and related t-cell initiated tissue destruction by administering HSA/CD24
US7744894B2 · kind B2 · utility
3Cited by
8References
6Claims
0Family size
Inventors
Key dates
| Filing date | May 13, 2005 |
| Grant date | Jun 29, 2010 |
| Priority date | — |
| Expiry date | Nov 13, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for blocking autoreactive T cell-initiated destruction of tissues in a mammal are provided. In one embodiment, the methods involve administering an HAS/CD24 polypeptide or fragment thereof. In some embodiments, the polypeptide or fragment is glycosylated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.